SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other ...
Jury selection is underway for Amanda Milsap, who is accused of offering a bribe to a witness. Milsap allegedly offered $10,000 to her ex-husband's former girlfriend to prevent her from testifying ...
First candidate from Tenvie’s product engine to enter clinical developmentPhase 1 first-in-human study to evaluate single and multiple ascending ...
Four major outlets spent a year building Hasan Piker into a Democratic asset. Jake Tapper spent one segment showing what they ...
Lower-extremity insertion of peripherally inserted central catheters (PICCs) is recommended in neonates to reduce tip malposition risk, yet primary malposition into the inferior vena cava (IVC) ...
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other ...
October 22, 2025—Access Vascular, Inc. announced that the FDA cleared a new indication for its single-lumen Mimix HydroMid midline catheter and its single- and dual-lumen HydroPICC peripherally ...
Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation ...
ABSTRACT: PICC is widely used in clinical practice due to its advantages of easy insertion, safety and cost-effectiveness, providing a reliable intravenous infusion pathway for patients undergoing ...
Note: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results